Histone deacetylase (HDAC) inhibitors potentiate the antiproliferative and apoptotic effects induced by the novel ribonucleotide reductase (RR) inhibitor 3'-metil-adenosine (3'-Me-Ado) in promyelocitic leukemia cell lines

Research output: Contribution to conferenceOther

Original languageEnglish
Pages75-75
Publication statusPublished - 2008

Cite this